Integrated multi-omics insight into the molecular networks of oxidative stress in triggering multiple sclerosis

Yudi Xu1, Xiaowei Zhang2, Yuyuan Zhang2

  • 1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.

PubMed

Insights

Oxidative stress contributes to multiple sclerosis (MS). This study identified key genes like HMGCL and TSFM in brain tissue as potential targets for MS, validated through in vitro experiments, offering new avenues for clinical intervention.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Molecular Biology

Background:

  • Oxidative stress (OS) is a critical factor in multiple sclerosis (MS) pathogenesis.
  • The precise molecular mechanisms linking OS to MS onset remain unclear.
  • Identifying causal genes is crucial for understanding MS development.

Purpose of the Study:

  • To identify potential causal genes linking oxidative stress to multiple sclerosis (MS).
  • To investigate the role of multi-omics data (eQTL, mQTL, pQTL) in OS-related genes in MS.
  • To explore potential therapeutic targets for MS based on genetic associations.

Main Methods:

  • Applied summary-data-based Mendelian randomization (SMR) to 1216 OS-related genes.
  • Utilized multi-omics SMR integrating expression, methylation, and protein quantitative trait loci (eQTL, mQTL, pQTL) from blood and brain tissues.
  • Performed Bayesian colocalization tests and validated findings in the FinnGen cohort and in vitro experiments.

Main Results:

  • Identified three genes (BACH2, TRAF3, MAPK3) associated with MS in blood.
  • Identified four genes (HMGCL, TSFM, TRAF3, HLA-B) associated with MS in brain tissue.
  • HMGCL and TSFM in brain tissue showed strong evidence and were validated in vitro, suggesting a direct role in MS.

Conclusions:

  • This study pinpoints specific genes, particularly HMGCL and TSFM in brain tissue, as potential causal contributors to MS.
  • The findings advance fundamental understanding of oxidative stress in MS.
  • Identified genes offer promising targets for future clinical interventions in MS treatment.